US FDA declines to approve Capricor's muscle disorder therapy-February 2024-www.financetom.com

US FDA declines to approve Capricor's muscle disorder therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA declines to approve Capricor's muscle disorder therapy

Jul 11, 2025 4:13 AM

July 11 (Reuters) - Capricor Therapeutics ( CAPR ) said

on Friday the U.S. Food and Drug Administration has declined to

approve its cell therapy for a type of muscle disorder.

(Reporting by Christy Santhosh in Bengaluru)

Previous page： Loar Holdings Prices Stock Offering Next page： Mercedes-Benz reshuffles management board

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Loar Holdings Prices Stock Offering

Dec 11, 2024

03:32 AM EST, 12/11/2024 (MT Newswires) -- Loar Holdings ( LOAR ) said late Tuesday it priced a public offering of about 5.8 million common shares at $85 per share. The offering consists of about 3.9 million shares from the company and about 1.9 million shares from certain shareholders. The underwriters have been granted 30-day option to purchase up to...

Mercedes-Benz reshuffles management board

Dec 11, 2024

(Reuters) - German carmaker Mercedes-Benz will reshuffle its management board with four new members, the firm said on Wednesday, with changes due to take effect in 2025. Sabine Kohleisen, Renata Jungo Bruengger, responsible for Integrity, Governance and Sustainability, and Hubertus Troska, board member for Greater China, are to leave the board as their contracts expire, the company added. Olaf Schick,...

Becton Dickinson Insider Sold Shares Worth $1,130,529, According to a Recent SEC Filing

Dec 11, 2024

03:29 AM EST, 12/11/2024 (MT Newswires) -- Roland Goette, Executive Vice President and President, EMEA, on December 06, 2024, sold 5,121 shares in Becton Dickinson ( BDX ) for $1,130,529. Following the Form 4 filing with the SEC, Goette has control over a total of 15,516 shares of the company, with 14,217 shares held directly and 1,299 controlled indirectly. SEC...

QuantumScape Insider Sold Shares Worth $2,124,029, According to a Recent SEC Filing

Dec 11, 2024

03:31 AM EST, 12/11/2024 (MT Newswires) -- Jagdeep Singh, Director, on December 09, 2024, sold 400,541 shares in QuantumScape ( QS ) for $2,124,029. Following the Form 4 filing with the SEC, Singh has control over a total of 9,137,603 shares of the company, with 2,563,767 shares held directly and 6,573,836 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1811414/000156218024008314/xslF345X05/primarydocument.xml ...